| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Poon Christine A serves as a Director at PRS and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 0 buys and 37 sells. Those positions are worth an estimated $2.1M at current prices.
Historically, Poon Christine A's trades have earned a middling insider score of 51/100 across 5 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -1.7%.
The biggest single holding is PRS (~$1.2M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2025 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 6,500 | $654.27 | $4,252,745.32 | -73.4% | +18.1% | - | |
| Aug 15, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 10,838 | $1,158.17 | $12,552,284.50 | -83.3% | -31.6% | -50.6% | |
| Aug 23, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 12,280 | $839.97 | $10,314,828.70 | -85.8% | -5.0% | +41.3% | |
| Aug 9, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $620.91 | $9,313,598.80 | -88.9% | +20.7% | +26.3% | |
| Aug 27, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $668.09 | $10,021,405.81 | -89.9% | -3.0% | -10.1% | |
| Aug 28, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 40,000 | $601.22 | $24,048,714.81 | -96.5% | - | - |